Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir, covering 2017-11-24 to 2017-12-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Hepatitis C Virus Genotype 1b-Infected Adults [Phase 3]